Tagged with S

Hong Kong Christian Hogg, executive director and CEO of Chi-Med, discusses the company’s rapid development in tandem with the growth of the Chinese pharmaceutical market, brining genuine global pharmaceutical innovation to China, and the state of Hong Kong’s biotech industry. Hutchison China MedTech (Chi-Med) is entering a very exciting stage of its…

Colombia J&J Medical Devices regional VP Mircea Cubillos discusses the long-term vision for J&J in Colombia and Latin America. Moreover, he speaks about the company’s strategy for emerging markets, the importance of the collaboration with stakeholders and government actors in the medical devices sector, as well as his personal motivation to…

Indonesia Wiwy Sasongko, MD at QuintilesIMS Indonesia, describes his efforts to continuously improve the services provided to his clients and explains the revolution that the universal healthcare coverage program in Indonesia (JKN) is creating in the domestic healthcare industry. The merger of Quintiles and IMS was completed in October 2016. How…

Colombia Executive president of ACEMI (La Asociación Colombiana de Empresas de Medicina Integral), Jaime Arias, discusses fostering the constructive participation of all actors in the Colombian healthcare sector and the challenges that need to be addressed to develop the sustainability of the healthcare system in the long-term. Could you explain ACEMI’s…

Indonesia Omar Luqmaan Harris, GM at GSK Indonesia, discusses the commitment of the Indonesian affiliate to the global organization’s mission, as well as their focus on being the best place to work, with the highest patient focus, and the best customer engagement. Mr. Harris, what have been your main areas of…

Colombia With over a decade as executive director of the Pharmaceutical Chamber of ANDI (The Colombian National Business Association), Rodrigo Arcila Gomez, shares his optimistic insights on the growth of the sector, the current status of pricing negotiations, his key achievements, and the need for a pharmaceutical landscape built on trust.…

Indonesia Dr. Kuntjoro Adi Purjanto, Chairman of PERSI (National Association of Hospitals in Indonesia), explains the role that public and private hospitals are playing to successfully realize the national healthcare goals and the active collaboration of PERSI with the government to enhance the Indonesian hospital eco-system. Could you please introduce yourself…

Colombia Gustavo Morales, Executive Director of the Association of Pharmaceutical Research and Development Laboratories (AFIDRO) and proud advocate of intellectual property has successfully changed Colombian public opinion on the pharmaceutical industry. In this interview, Gustavo explains how recent regulations will increase the demand of pharmaceutical products as well as the incentives…

Indonesia Herny Prasetya, President of the International Society of Pharmaceutical Engineering (ISPE) in Indonesia highlights the importance of the implementation of global guidelines in Indonesia and wishes to focus on human capital, compliance and local API manufacturing for ISPE’s members. Could you please introduce to our international audience what are the…

Ukraine Dmytro Spitsyn, General Manager of Teva Ukraine, which proudly stands as the largest international company operating in the country, documents the challenges he faced and the strategies he implemented to overcome the 2013 crisis in Ukraine, while Teva has been positioning itself as a company committed to increasing life expectancy…

Indonesia Dede Yusuf is advocating for more people in Indonesia to take up a healthy lifestyle and, through his position of Chairman of Commission IX of the House of Representatives, is aiming to improve the healthcare sector of his country both by boosting local companies and improving health education. Could you…

Colombia In explaining the role of the Colombia National Food and Drug Surveillance Institute (INVIMA) and its impact on the regulatory landscape of the healthcare sector, Javier Guzman, Executive Director, centres the discussion on four key pillars: institutional strengthening, efficiency, transparency and competitiveness. He speaks about his main priorities, the Colombian…